Mitozz is the best choice for mitochondrial support See why ➝

    End of Content.

    Shop Mitozz

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Search Papers by Specialization

    Human Pharmacokinetic Study of Purified (−)-Epicatechin

    Study Title: Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (−)-epicatechin in healthy volunteers

    Citation: Barnett et al., 2015 · Food & Function

    What the Study Found: This phase I, open-label human study evaluated purified (−)-epicatechin in healthy volunteers. Participants received single oral doses of 50, 100, or 200 mg, or repeated 50 mg doses once or twice daily for 5 days. The researchers measured absorption, metabolism, early safety, and selected biological markers related to nitric oxide signaling, mitochondrial enzyme activity, and muscle-related pathways.

    The authors reported that purified (−)-epicatechin was rapidly absorbed and metabolized, with several metabolites detected in blood. After repeated dosing, the study observed changes in selected biomarkers, including plasma nitrite, platelet mitochondrial enzyme activity, and follistatin measures. No adverse effects attributed to (−)-epicatechin were reported in this small short-term study.

    What this means in real life: This study helps distinguish purified (−)-epicatechin from cocoa, dark chocolate, or mixed flavanol products. It shows that purified (−)-epicatechin can be absorbed and measured in humans, and that it may influence biological pathways connected to nitric oxide signaling, vascular biology, mitochondrial enzyme activity, and muscle-related signaling.

    These findings are preliminary. The study did not test whether (−)-epicatechin improves fatigue, exercise performance, recovery, cardiovascular outcomes, or any disease condition. Larger and longer clinical trials would be needed to evaluate those questions.

    Clinical Relevance: Human phase I pharmacokinetic and partial pharmacodynamic study in healthy volunteers; purified (−)-epicatechin, nitric oxide metabolites, platelet mitochondrial enzyme activity, and follistatin signaling; not a randomized efficacy trial and not evidence that (−)-epicatechin treats, prevents, or cures disease.

    Related Content:

    View Paper

    Epicatechin and Muscle Wasting After Spinal Cord Injury

    Study Title: (-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system

    Citation: Gonzalez-Ruiz et al., 2020 · Molecular Biology Reports

    What the Study Found: This study evaluated (-)-epicatechin in a mouse model of complete spinal cord transection, a severe injury model associated with rapid skeletal muscle wasting. The authors focused on the ubiquitin-proteasome system, a major pathway involved in protein breakdown during muscle atrophy. Compared with untreated injured animals, (-)-epicatechin-treated mice showed reduced loss of muscle mass and changes in molecular markers related to protein degradation. The findings suggest that (-)-epicatechin helped blunt muscle wasting in this model by influencing proteasome-related signaling and muscle catabolism pathways.

    What this means in real life: After severe spinal cord injury, muscles can lose size and functional capacity because nerve input, movement, and normal loading are disrupted. This animal study suggests that (-)-epicatechin may affect some of the molecular pathways that drive muscle breakdown after spinal cord injury. It does not show that (-)-epicatechin treats spinal cord injury or prevents muscle loss in humans, but it adds to the scientific literature on epicatechin, neuromuscular biology, and skeletal muscle preservation under extreme disuse conditions.

    Clinical Relevance: Animal study, complete spinal cord transection model, skeletal muscle wasting, ubiquitin-proteasome signaling, and neuromuscular injury biology; not direct clinical trial evidence.

    Related Content:

    View Paper

    (+)-Epicatechin and Spinal Cord Injury Recovery in Rats

    Epicatechin, Muscle Growth Markers, and Age-Related Muscle Function

    Study Title: Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation

    Citation: Gutierrez-Salmean et al., 2014 · The Journal of Nutritional Biochemistry

    What the Study Found: This study examined age-related changes in skeletal muscle growth and differentiation markers in mice and humans, then tested short-term (-)-epicatechin exposure. In aged mice, myostatin and senescence-associated β-galactosidase were higher, while follistatin and Myf5 were lower. (-)-Epicatechin reduced myostatin and β-galactosidase and increased markers associated with muscle growth. In the human proof-of-concept portion, older muscle showed a similar age-related pattern, and seven days of (-)-epicatechin increased hand grip strength and the plasma follistatin-to-myostatin ratio.

    What this means in real life: This study supports the idea that aging muscle is affected not only by loss of mass, but also by changes in the signaling environment around muscle growth, differentiation, and cellular senescence. In this early research, (-)-epicatechin was associated with more favorable muscle-related markers and a short-term increase in grip strength. This does not mean (-)-epicatechin treats sarcopenia or reverses muscle aging in humans. It does suggest that muscle resilience and healthy aging may be linked to molecular signals that can be studied and potentially supported.

    Clinical Relevance: Mouse and small human proof-of-concept study, aging skeletal muscle, muscle growth and differentiation markers, and short-term (-)-epicatechin exposure.

    Related Content:

    View Paper

    Exercise, Mitochondrial Quality Control, and Aging

    Study Title: The role of exercise-mediated mitochondrial quality control remodeling in aging

    Citation: Cai et al., 2026 · Frontiers in Cell and Developmental Biology

    What the Study Found: This review examined how exercise influences mitochondrial quality control during aging. The authors discussed several interrelated processes, including mitochondrial biogenesis, mitochondrial dynamics, mitophagy, proteostasis, and mitochondrial stress responses. They described how aging is associated with reduced mitochondrial function and impaired quality-control capacity, while exercise can activate signaling pathways that help maintain mitochondrial turnover, repair, and adaptation. The review frames exercise as a physiological stimulus that may help remodel mitochondrial quality-control systems across aging tissues.

    What this means in real life: This paper supports a practical idea: exercise is not only about burning calories or building muscle. It also sends biological signals that help cells maintain and renew their mitochondrial systems. Over time, that may matter for energy capacity, recovery, and resilience during aging. This does not mean exercise reverses aging or that any single strategy can guarantee mitochondrial health. The practical takeaway is that consistent movement helps train the systems that build, repair, and recycle mitochondria.

    Clinical Relevance: Review article, focused on exercise, aging, mitochondrial quality control, mitophagy, mitochondrial dynamics, biogenesis, and cellular resilience.

    Related Content:

    View Paper

    (−)-Epicatechin, Muscle Fatigue, and Mitochondrial Capacity

    Study Title: (–)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle

    Citation: Nogueira et al., 2011 · The Journal of Physiology

    What the Study Found: This mouse study tested whether 15 days of low-dose (−)-epicatechin could affect exercise performance, muscle fatigue resistance, muscle capillarity, and mitochondrial markers. Twenty-five 1-year-old male mice were assigned to four groups: water, water plus exercise, (−)-epicatechin, and (−)-epicatechin plus exercise. The (−)-epicatechin groups received 1 mg/kg twice daily by oral gavage. The exercise groups performed treadmill exercise during the study period.

    The researchers found that (−)-epicatechin treatment was associated with significant increases in treadmill performance, greater resistance to muscle fatigue, increased skeletal muscle capillarity, and higher markers of mitochondrial structure and oxidative metabolism. These included oxidative phosphorylation complexes, mitofilin, porin, Tfam, mitochondrial volume, and cristae abundance.

    The combination of (−)-epicatechin and exercise produced further increases in several markers compared with (−)-epicatechin alone, including oxidative phosphorylation-complex proteins, mitofilin, porin, and capillarity. The authors concluded that (−)-epicatechin, alone or combined with exercise, produced structural and metabolic changes in skeletal and cardiac muscle associated with greater endurance capacity.

    Clinical Relevance: Animal study, skeletal and cardiac muscle, mitochondrial and exercise physiology model.

    What this means in real life: This paper helps explain why muscle fatigue is closely tied to cellular energy capacity. Muscles do not only need calories to perform, they also need oxygen delivery, capillary support, and mitochondria capable of producing ATP efficiently under demand.

    In this study, (−)-epicatechin influenced several of those systems in mice. That does not mean it replaces exercise or proves the same effect in humans. It does suggest that (−)-epicatechin is relevant to the study of mitochondrial structure, aerobic capacity, fatigue resistance, and muscle performance.

    Related Content

    View Paper

    Epicatechin-Rich Green Tea Extract and Muscle Strength in Older Adults

    Study Title: (−)-Epicatechin-Enriched Extract from Camellia sinensis Improves Regulation of Muscle Mass and Function: Results from a Randomized Controlled Trial

    Citation: Seo et al., 2021 · Antioxidants

    What the Study Found: This randomized, double-blind, placebo-controlled trial tested tannase-treated green tea extract in healthy Korean adults aged 60 or older. The extract contained higher levels of (−)-epicatechin and gallic acid after enzymatic treatment. Participants took 600 mg/day for 12 weeks. Compared with placebo, the treatment group showed improved lower-extremity flexor strength, suppression of grip-strength decline, and changes in blood myostatin, a regulator associated with muscle mass. The study did not include an added exercise program, so the findings relate to supplementation alone within this trial design.

    What this means in real life: This study supports the idea that certain plant compounds, including (−)-epicatechin-rich green tea extract, may influence pathways related to muscle strength and age-related muscle maintenance. For older adults, that matters because strength, grip, and muscle preservation are closely tied to mobility and independence. The findings are promising, but they should be understood as one human study using a specific tannase-treated green tea extract, not proof that all green tea products or all epicatechin supplements produce the same result.

    Clinical Relevance: Human randomized controlled trial, older adults, muscle strength and myostatin regulation, early clinical evidence.

    Related Content:
    • Want to understand how mitochondrial dysfunction can feel day to day? → What Does “Mitochondrial Dysfunction” Actually Feel Like?
    • Curious how long mitochondrial adaptation may take? → How Long Does It Take to Improve My Mitochondria? A Realistic Timeline for Beginners
    • Want practical ways to build cellular energy capacity? → How to Repair and Maintain Mitochondrial Health Naturally

    View Paper

    Epicatechin, Muscle Growth Markers, and Age-Related Muscle Function

    Study Title: Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation

    Citation: Gutierrez-Salmean et al., 2014 · The Journal of Nutritional Biochemistry

    What the Study Found: This study examined age-related changes in skeletal muscle growth and differentiation markers in mice and humans, then tested short-term (-)-epicatechin exposure. In aged mice, myostatin and senescence-associated β-galactosidase were higher, while follistatin and Myf5 were lower. (-)-Epicatechin reduced myostatin and β-galactosidase and increased markers associated with muscle growth. In the human proof-of-concept portion, older muscle showed a similar age-related pattern, and seven days of (-)-epicatechin increased hand grip strength and the plasma follistatin-to-myostatin ratio.

    What this means in real life: This study supports the idea that aging muscle is affected not only by loss of mass, but also by changes in the signaling environment around muscle growth, differentiation, and cellular senescence. In this early research, (-)-epicatechin was associated with more favorable muscle-related markers and a short-term increase in grip strength. This does not mean (-)-epicatechin treats sarcopenia or reverses muscle aging in humans. It does suggest that muscle resilience and healthy aging may be linked to molecular signals that can be studied and potentially supported.

    Clinical Relevance: Mouse and small human proof-of-concept study, aging skeletal muscle, muscle growth and differentiation markers, and short-term (-)-epicatechin exposure.

    Related Content:

    View Paper

    Oxidative Stress Regulation in Skeletal Muscle Under Clinical Metabolic Strain

    Study Title:
    (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients

    Citation:
    Ramírez-Sánchez et al., 2013. International Journal of Cardiology

    What the Study Found:
    In patients with heart failure and type 2 diabetes, (−)-epicatechin-rich cocoa modulated key oxidative-stress regulators in skeletal muscle. The treatment influenced redox biology in clinically stressed tissue. These changes occurred in a real-world patient population.

    What this means in real life:
    Heart failure and type 2 diabetes place heavy oxidative stress on mitochondria in skeletal muscle, accelerating fatigue and weakness. This study shows that (−)-epicatechin can help rebalance those stress regulators, protecting cellular energy production under chronic disease conditions. Mitochondrial support is therefore a valuable strategy for maintaining muscle function when the heart and metabolism are under strain.

    Related Content

    View Paper

    Skeletal Muscle Structure, Regeneration, and Cardiometabolic Health

    Study Title: Perturbations in skeletal muscle sarcomere structure in patients with heart failure and Type 2 diabetes: restorative effects of (−)-epicatechinrich cocoa

    Citation: Taub et al., 2013 · Clinical Science

    What the Study Found: In patients with heart failure and type 2 diabetes, (−)-epicatechin-rich cocoa restored dystrophin-associated protein complex levels and improved sarcomeric microstructure in skeletal muscle. It also triggered coordinated changes in markers of muscle growth and differentiation consistent with myofiber regeneration. Maximum oxygen consumption increased by approximately 24%.

    What this means in real life: Chronic heart and metabolic conditions can disrupt the tiny structural machinery inside muscle fibers, impairing contraction and energy use. This study shows that (−)-epicatechin can help repair sarcomere architecture and promote regeneration, directly supporting the mitochondrial environment needed for healthy muscle function. At Mitozz we focus on mitochondrial health because restored cellular energy helps tissues rebuild and perform even under cardiometabolic stress.

    Related Content

    View Paper

    Mitochondrial Biogenesis, Muscle Regeneration, and Human Neuromuscular Disease

    Study Title:
    (-)-Epicatechin induces mitochondrial biogenesis and markers of muscle regeneration in adults with Becker muscular dystrophy

    Citation:
    McDonald et al., 2021. Muscle & Nerve

    What the Study Found:
    In adults with Becker muscular dystrophy, (−)-epicatechin treatment increased markers of mitochondrial biogenesis. It also elevated markers of muscle regeneration. The results suggest activation of pathways involved in energy production and tissue repair.

    What this means in real life:
    In neuromuscular conditions, damaged mitochondria limit the muscle’s ability to repair and generate energy. This human study demonstrates that (−)-epicatechin can stimulate mitochondrial biogenesis and regeneration signals, helping restore cellular energy capacity where it’s most needed. Supporting mitochondrial health offers a practical way to aid muscle resilience even in challenging conditions.

    Related Content

    View Paper

    Flavonoids, Mitochondria, and Skeletal Muscle Health

    Study Title: Beneficial Effects of Flavonoids on Skeletal Muscle Health: A Systematic Review and Meta-Analysis

    Citation: Munguía et al., 2022 · Journal of Medicinal Food

    What the Study Found: This systematic review and meta-analysis evaluated preclinical and clinical studies on flavonoids and skeletal muscle health. The authors included 103 studies, 80 in rodents and 23 in humans, covering flavonoids from sources such as green tea, cacao, and other polyphenol-rich compounds. In the meta-analysis, flavonoid supplementation was associated with improved endurance performance, skeletal muscle cross-sectional area, and muscle mass in rodent studies, although heterogeneity was high. The review also summarized reported effects on mitochondrial bioenergetics, oxidative stress, inflammation, apoptosis, autophagy, and muscle metabolism.

    What this means in real life: This review supports the idea that flavonoids, especially flavan-3-ols such as epicatechin-related compounds, may influence several biological systems tied to muscle quality and resilience. The strongest pooled evidence came from preclinical studies, while the authors noted that clinical evidence was still limited. This does not mean flavonoids treat sarcopenia, cachexia, or muscle disease. It does suggest that skeletal muscle health is closely connected to mitochondrial function, oxidative balance, metabolism, and recovery pathways that are worth studying further in humans.

    Clinical Relevance: Systematic review and meta-analysis of preclinical and clinical studies, focused on flavonoids, skeletal muscle performance, muscle mass, mitochondrial function, and muscle health.

    Related Content:

    View Paper

    Fatigue Resistance, Oxidative Capacity, and Muscle Energy

    Study Title:
    (–)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle

    Citation:
    Nogueira et al., 2011. The Journal of Physiology

    What the Study Found:
    In mice, (−)-epicatechin supplementation significantly increased treadmill performance and enhanced in-situ muscle fatigue resistance. It also improved oxidative capacity in skeletal muscle tissue. These outcomes were linked to mitochondrial and oxidative-metabolism effects.

    What this means in real life:
    Muscle fatigue often stems from declining mitochondrial efficiency and reduced ability to produce energy under demand. This study shows that (−)-epicatechin can directly boost fatigue resistance and oxidative capacity, helping muscles work longer and recover better. At Mitozz we emphasize mitochondrial health because stronger cellular energy production translates into greater endurance and daily vitality.

    Related Content

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community